BMRA - Biomerica, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue5/31/20185/31/20175/31/20165/31/2015
Total Revenue5,564.1855,791.675,139.8164,962.373
Cost of Revenue3,809.7853,769.8793,615.7743,420.567
Gross Profit1,754.42,021.7911,524.0421,541.806
Operating Expenses
Research Development1,398.3681,130.635780.333733.64
Selling General and Administrative1,837.7871,845.7891,570.6611,478.761
Non Recurring----
Others----
Total Operating Expenses7,045.946,746.3035,966.7685,632.968
Operating Income or Loss-1,481.755-954.633-826.952-670.595
Income from Continuing Operations
Total Other Income/Expenses Net47.72746.07230.96524.161
Earnings Before Interest and Taxes-1,481.755-954.633-826.952-670.595
Interest Expense-0.037-0.282-0.167-0.167
Income Before Tax-1,434.028-908.561-795.987-646.434
Income Tax Expense31.8-703.8-315.024
Minority Interest----
Net Income From Continuing Ops-1,465.828-908.561-1,499.787-331.41
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-1,465.828-908.561-1,499.787-331.41
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-1,465.828-908.561-1,499.787-331.41